Warrants and Warrants Liability (Details Textual) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2011 Biocontrol Limited [Member]	Dec. 31, 2013 Convertible Notes Payable [Member]	Dec. 31, 2013 Series B Convertible Preferred Stock [Member]	Dec. 31, 2013 Common Stock [Member]	Dec. 31, 2013 Private Placement [Member] Series B Convertible Preferred Stock [Member]	Dec. 31, 2013 Private Placement [Member] Common Stock [Member]
Class of Warrant or Right [Line Items]
Stock Issued During Period, Shares, New Issues2						72,007,000		72,007,000
Stock Issued During Period, Exercise Price, New Issues2								$ 0.25
Warrants Issued During the Period, Terms Of Expiration			December 2016	February through May 2018			June 2018	December 2018
Asset Management Fees								$ 1,442,000
Warrants Issued During the Period, Number of Warrants			1,355,164	7,030,387	12,499,996		30,040,194
Warrants Issued During the Period, Exercise Price of Warrants			$ 0.46	$ 0.14	$ 0.14		$ 0.14
Warrants Issuance Costs							757,000
Share Price	$ 0.58	$ 0.50
Fair Value Adjustment of Warrants	2,261,000
Derivative warrants liability	$ 18,772,000	$ 16,511,000